| UHC Commercial Medical & Drug | Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions – Commercial and Individual Exchange Medical Policy | 2026-08-01 |
| UHC Commercial Medical & Drug | Noncontact Warming Therapy, Ultrasound Therapy, and Fluorescence Imaging for Wounds – Commercial and Individual Exchange Medical Policy | 2026-08-01 |
| UHC Commercial Medical & Drug | Outpatient Surgical Procedures – Site of Service – Commercial and Individual Exchange Medical Policy | 2026-08-01 |
| UHC Commercial Medical & Drug | Private Duty Nursing Services – Commercial and Individual Exchange Medical Policy | 2026-08-01 |
| UHC Commercial Medical & Drug | Skin and Soft Tissue Substitutes – Commercial and Individual Exchange Medical Policy | 2026-08-01 |
| UHC Commercial Medical & Drug | Surgery of the Elbow – Commercial and Individual Exchange Medical Policy | 2026-08-01 |
| BCBS Premera WA AK Clinical | Laboratory Testing Investigational Services | 2026-08-01 |
| Medical Mutual | Hypoglossal Nerve Stimulation for Treatment of | 2026-08-01 |
| Medical Mutual | Tecentriq Hybreza® (atezolizumab and hyaluronidase-tqjs) (EOV) | 2026-08-01 |
| UHC Medicaid Medical & Drug | Beds and Mattresses – Community Plan Medical Policy | 2026-08-01 |